| Name | SMAP-2 |
|---|
| Description | SMAP-2 (DT-1154) is an orally bioavailable phosphatase 2A (PP2A) activator which binds to the PP2A Aα scaffold subunit to drive conformational changes in PP2A. SMAP-2 (DT-1154) inhibits the growth of KRAS-mutant lung cancers [1]. |
|---|---|
| Related Catalog | |
| Target |
PP2A[1] |
| References |
| Molecular Formula | C27H27F3N2O4S |
|---|---|
| Molecular Weight | 532.57 |